VBI Vaccines Inc.

Quick facts

Phase 3 pipeline

• Sci-B-Vac-Lot A · Immunology / Infectious Disease
  Sci-B-Vac is a recombinant hepatitis B vaccine designed to provide improved immunogenicity and broader protection against hepatitis B virus variants.
• Sci-B-Vac-Lot B · Infectious Disease
  Sci-B-Vac-Lot B is a vaccine that stimulates an immune response against the hepatitis B virus.

Phase 1 pipeline

• VBI-1501 1.0 μg
• VBI-1901
• VBI-2901a
• VBI-2902a
• VBI-2905a

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• VBI Vaccines Inc. portfolio CI brief
• VBI Vaccines Inc. pipeline updates RSS